ACS Biomarker Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Out of Business

ACS Biomarker General Information

Description

Developer of novel biomarkers designed to improve the prognosis and management of cardiac diseases. The company's novel biomarkers conducts miRNA and protein-based research from the clinical samples that is used to distinguish between the different heart failure subtypes and optimally assess the clinical condition of a heart failure patient, enabling medical practitioners to engage into a quick and simplified diagnostic procedure that leads to a better understanding of the cardiovascular status resulting in better treatment decisions and improved patient outcomes.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Meibergdreef 39
  • 1105 AZ Amsterdam
  • Netherlands
+31 020
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • Meibergdreef 39
  • 1105 AZ Amsterdam
  • Netherlands
+31 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ACS Biomarker Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Sep-2018 Completed Out of Business
1. Early Stage VC 01-Jan-2011 Completed Generating Revenue
To view ACS Biomarker’s complete valuation and funding history, request access »

ACS Biomarker Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel biomarkers designed to improve the prognosis and management of cardiac diseases. The company's novel
Biotechnology
Amsterdam, Netherlands
6 As of 2016

West Jordan, UT
 

Montreal, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ACS Biomarker Competitors (9)

One of ACS Biomarker’s 9 competitors is InCarda Therapeutics, a Venture Capital-Backed company based in West Jordan, UT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InCarda Therapeutics Venture Capital-Backed West Jordan, UT
DalCor Pharmaceuticals Venture Capital-Backed Montreal, Canada
Klotho Therapeutics Formerly VC-backed San Diego, CA
Cytokinetics Formerly VC-backed South San Francisco, CA
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
You’re viewing 5 of 9 competitors. Get the full list »

ACS Biomarker Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ACS Biomarker FAQs

  • When was ACS Biomarker founded?

    ACS Biomarker was founded in 2007.

  • Where is ACS Biomarker headquartered?

    ACS Biomarker is headquartered in Amsterdam, Netherlands.

  • What is the size of ACS Biomarker?

    ACS Biomarker has 6 total employees.

  • What industry is ACS Biomarker in?

    ACS Biomarker’s primary industry is Biotechnology.

  • Is ACS Biomarker a private or public company?

    ACS Biomarker is a Private company.

  • What is ACS Biomarker’s current revenue?

    The current revenue for ACS Biomarker is .

  • Who are ACS Biomarker’s competitors?

    InCarda Therapeutics, DalCor Pharmaceuticals, Klotho Therapeutics, Cytokinetics, and Genetix Biotherapeutics are some of the 9 competitors of ACS Biomarker.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process